Antiretroviral therapy with or without opportunistic infection treatment
Part of Immune system & allergy, Infections clinical trials.
This study tracks how well HIV medications work in people who also have opportunistic infections—infections that take advantage of a weakened immune system. It aims to learn which treatments work best in real life, which could help improve care for people with HIV and these infections.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older and have been diagnosed with HIV.
- You either have an opportunistic infection (like tuberculosis, Pneumocystis pneumonia, or cryptococcal meningitis) and are starting treatment for it, OR you do not have an opportunistic infection.
- You are planning to start or are already taking HIV medication (antiretroviral therapy).
- You do not have severe mental health conditions (like schizophrenia or severe depression) or a recent history of drug or alcohol dependence.
- You are willing to be followed for a long period and attend regular check-ups.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether giving an immune checkpoint inhibitor (a drug that helps your immune system fight infections) can help treat opportunistic infections in people with AIDS that are hard to get rid of. It aims to see if the treatment is safe and works for these stubborn infections.
This is an observational study (not a new drug) that tracks how living with HIV can change over time in different treatment situations. It may help researchers understand long-term effects of the modern “protease inhibitor era” and improve future care.
This trial is testing new treatments for cryptococcal meningitis, a serious brain infection, in people living with HIV. It aims to find the best way to treat this infection with fewer side effects.
This is an observational study that follows people with HIV who are taking HIV medicines (antiretroviral therapy). It may help researchers understand how treatment is going and what factors relate to doing well on therapy.
This trial helps doctors find the best way to combine HIV medicines (antiretroviral therapy) with lymphoma treatment for people who have both HIV and AIDS-related lymphoma. The goal is to improve your overall care and outcomes.
This study tests new treatments to help people with HIV who have low CD4 counts despite antiretroviral therapy. It aims to improve immune function and reduce the risk of infections.
Hear when a new Opportunistic Infections, HIV Related trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.